HomeMRSN • NASDAQ
add
Mersana Therapeutics Inc
Previous close
$1.30
Day range
$0.69 - $1.12
Year range
$0.69 - $6.28
Market cap
83.27M USD
Avg Volume
1.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 12.60M | 63.65% |
Operating expense | 9.86M | -23.50% |
Net income | -11.50M | 72.39% |
Net profit margin | -91.29 | 83.13% |
Earnings per share | -0.09 | 67.57% |
EBITDA | -11.67M | 66.95% |
Effective tax rate | -3.77% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 155.17M | -35.61% |
Total assets | 169.53M | -35.52% |
Total liabilities | 168.48M | -20.04% |
Total equity | 1.05M | — |
Shares outstanding | 123.53M | — |
Price to book | 130.00 | — |
Return on assets | -17.31% | — |
Return on capital | -81.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -11.50M | 72.39% |
Cash from operations | -8.58M | 81.39% |
Cash from investing | 28.47M | -72.57% |
Cash from financing | -23.00K | 84.25% |
Net change in cash | 19.87M | -65.47% |
Free cash flow | -2.38K | 99.99% |
About
Founded
2001
Website
Employees
123
